Sentry Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Sentry Investments's PFE Position: Q1 2018 in Review
Sentry Investments reduced its Pfizer (PFE) stake by 40% in Q1 2018, selling an estimated $36.2M and leaving 1,586,323 shares worth $53.4M. The position accounts for 0.8% of the portfolio, ranked #40.
Sentry Investments first reported a position in PFE in Q1 2017 and has held it in 5 quarters since. The position peaked at $99.6M in Q3 2017. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.
- Sentry Investments held 1,586,323 shares of Pfizer worth $53.4M as of Q1 2018.
- Sentry Investments sold 1,052,103 Pfizer shares in Q1 2018, an estimated $36.2M.
- Pfizer made up 0.8% of Sentry Investments's portfolio in Q1 2018, its #40 holding.
- Sentry Investments first reported a position in Pfizer in Q1 2017 and has held it in 5 quarters since.
- Sentry Investments's Pfizer position peaked at $99.6M in Q3 2017.
- 2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.
Based on Sentry Investments's 13F filing for Q1 2018, filed 11 May 2018.